Drug Manufacturers - Specialty & Generic | Healthcare
Aurobindo Pharma Limited, a biopharmaceutical company, engages in the manufacture of generic formulations and active pharmaceutical ingredients in India, the United States of America, Europe, Puerto Rico, and internationally. The company offers formulation in form of oral solids, liquids, injectables, and vaccines, as well as over-the-counter drugs; and active pharmaceutical ingredients (APIs), biosimilars, biocatalysts, peptides, and hormones targeting key therapeutic areas, including central nervous system, cardiovascular, respiratory, antibiotics, anti-retroviral, anti-diabetics, gastroenterology, oncology, and dermatology. It also provides antiretroviral drugs for the people and children living with HIV; and provides project-based chemistry contract services that cover the clinical stage through to manufacturing and management of the entire drug lifecycle in the API space for sterile and non-sterile penicillin's, cephalosporins, penems, and non-beta lactams. The company was incorporated in 1986 and is headquartered in Hyderabad, India.
Market Cap
675763126272
Current Price
1163.5
52 Week Range
1010.0 - 1592.0
Previous Close
1170.9
Open
1194.3
Sector
Healthcare
Address
Galaxy, Plot No. 1, 22nd-24th Floor Plot No.1, Survey No.83/1 Hyderabad Knowledge City,Raidurg Panmakt, Hyderabad, 500032, India
Phone
+91-40667-25000
Fax
+91-40670-74044
Website
https://www.aurobindo.com
Day Low
1162.9
Day High
1194.3
Dividend Yield
0.4
PE Ratio
19.29519
Earnings Per Share
60.3
Beta
0.217
EBITDA
66054397952
Book Value
562.371
EPS
69.67041
Name | Title | Age | Year Born |
---|---|---|---|
Mr. Kambam Nithyananda Reddy | Vice Chairman & MD | 66 | 1958 |
Mr. Mettu Madan Mohan Reddy | Whole-Time Director | 64 | 1960 |
Dr. Makkapati Satakarni B.E., M.B.A., Ph.D. | President of Biologics, CEO of Biologics, Vaccines and Peptid & Director | 43 | 1981 |
Mr. Santhanam Subramanian | Chief Financial Officer | 63 | 1961 |
Dr. S. Vijaya Kumar | President of Technical | 58 | 1966 |
Mr. B. Adi Reddy | Compliance Officer & Company Secretary | - | - |
Mr. G. P. Prasad | Senior Vice President of Global Finance & Operations | - | - |
Dr. Sudhir Bimal Singhi | Head of Global Finance Operations | 55 | 1969 |
Dr. A. Rama Mohana Rao | Chief Quality Officer -Corporate QA | 62 | 1962 |
Dr. V. K. Handa | President of Chemical Research | 72 | 1952 |
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Find high-momentum stocks with strong forward PE ratios and moderate volatility for aggressive investors.
Explore stocks with high dividend yields and low debt-to-equity ratios for stable income.
Discover large-cap stocks with stable beta for lower volatility and reliable returns.
Find undervalued stocks with reasonable forward PE and market cap for value investors.
Discover stocks with strong 5-year revenue growth trading near their 52-week lows, ideal for long-term investment.
Explore high-beta stocks with significant price movement potential for risk-tolerant investors.
Discover mid to large-cap stocks with strong growth potential and attractive valuations.
Find affordable stocks with consistent dividend payouts for income-focused investors.